# Methylprednisolone sodium succinate

NDC: 43598-129
Generic name: Methylprednisolone sodium succinate
Labeler / Manufacturer: Dr. Reddy's Laboratories Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION
Routes: INTRAMUSCULAR, INTRAVENOUS
Marketing started: 20220324

FDA application: ANDA212396

## Active ingredients

- METHYLPREDNISOLONE SODIUM SUCCINATE: 125 mg/2mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"43598-129"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=43598-129
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=738753c7-507d-4881-5194-02dd7597768b